---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-056041"
form_type: "8-K"
ticker: "CYRX"
cik: "0001124524"
company_name: "Cryoport, Inc."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T19:54:41.990538+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Record Q1 revenue of $62.8M, up 20% YoY; net loss narrows to $0.16/share

## Summary
- Revenue $62.8M, +20% YoY (+23% constant currency); Biopharma/Pharma +19%, Animal Health +30%, Reproductive Medicine +13%.
- Net loss attributable to common stockholders $7.6M ($0.16/share) vs $15.4M ($0.31) YoY; adjusted EBITDA $2.9M vs $2.0M.
- Commercial cell and gene therapy revenue +28% YoY; supports 652 clinical trials (82 Phase 3) and 10 commercial therapies.
- Cash and short-term investments $522.6M; FY 2023 revenue guidance reaffirmed at $270-290M.
- New partnerships with Syneos Health (jan 2023), Inception Fertility (Mar 2023), and Boston IVF (Apr 2023).

## SEC filing metadata
- accession: 0001104659-23-056041
- form_type: 8-K
- ticker: CYRX
- cik: 0001124524
- company_name: Cryoport, Inc.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124524/000110465923056041/0001104659-23-056041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124524/000110465923056041/tm2314749d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-056041
- JSON: https://secwatch.observer/filing/0001104659-23-056041.json
- Plain text: https://secwatch.observer/filing/0001104659-23-056041.txt

## Key facts
- Earnings Releases
  Cryoport, Inc. reported the first quarter ended March 31, 2023 results: revenue $62.8 million.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $62.8 million
  - Result: reported results
  source text: We are pleased to report that we delivered record revenue of $62.8 million for the first quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124524/000110465923056041/0001104659-23-056041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.